<DOC>
	<DOC>NCT02894450</DOC>
	<brief_summary>The objective of this study was to investigate whether there is a link between clinical and biological variables and bioassay high xaban in elderly patients as part of an unscheduled hospitalization.</brief_summary>
	<brief_title>Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay Higher Among Those Aged Over 75 Years</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Age â‰¥ 75 years Entering SAU or MPG (Nantes University Hospital) as part of an unscheduled hospitalization for acute or subacute disease (About MPG, will be included patients admitted to the department within 48 hours of calling the doctor) In xaban to entry (dabigatran, rivaroxaban, Apixaban) for nonvalvular atrial fibrillation In whom hemostasis tests will be prescribed as part of usual care Patient has given its verbal agreement Exclusion criteria Patients with the following criteria may not be included: Patients refusing to participate in the study Patients under guardianship Inability to obtain the date and time of the last dose of xaban</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>oral anticoagulant</keyword>
	<keyword>bioassay</keyword>
	<keyword>elderly subject</keyword>
</DOC>